Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

COVID: Optimus Pharma submits phase 3 trials interim result for Molnupiravir capsules

Ruchika Sharma22 July 2021 2:00 PM IST

Optimus has approached DCGI to seek Emergency Use Authorization for Molnupiravir in India, the release said.

Zydus Cadila to submit ZyCoV-D additional data to DCGI this week: Sources

Ruchika Sharma22 July 2021 1:00 PM IST

New Delhi: Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit...

Granules India arm clears USFDA audit

Ruchika Sharma22 July 2021 12:03 PM IST

Hyderabad: Granules India Limited has announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company located...

Strong quarter from Johnson and Johnson as some operations return to normal

Ruchika Sharma22 July 2021 9:30 AM IST

New Delhi: Johnson & Johnson's second-quarter profit soared 73%, thanks to strong sales growth across all of its businesses, particularly its...

Zydus Cadila gets USFDA nod for cancer drug Ibrutinib

Ruchika Sharma21 July 2021 3:36 PM IST

Ahmedabad: Drugmaker, Zydus Cadila, today announced that the company has received tentative approval from the United States Food & Drug...

Biogen Alzheimer's drug: Former FDA adviser calls for wider probe into approval

Ruchika Sharma21 July 2021 2:00 PM IST

New Delhi: A federal probe of the U.S. Food and Drug Administration's approval of a controversial new Alzheimer's disease drug should look into why...

Dabur India eyes strong Ayurvedic healthcare products demand

Ruchika Sharma21 July 2021 1:56 PM IST

New Delhi: FMCG major and medicines to make up for any loss in the discretionary products business in case the COVID-19 pandemic worsens, according to...

Glenmark subsidiary IPO to open next week

Ruchika Sharma21 July 2021 11:00 AM IST

New Delhi: Glenmark Pharmaceuticals on Tuesday said the initial public offering of its subsidiary Glenmark Life Sciences will open on July 27.On July...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

HealthifyMe raises Rs 560 crore in Series C round

Ruchika Sharma21 July 2021 10:00 AM IST

Bengaluru: Leading AI health and fitness app HealthifyMe on Tuesday announced it has raised $75 million (nearly Rs 560 crore) in a Series C round led...

Bharat Biotech dossier under review for Covaxin EUL, says WHO

Ruchika Sharma20 July 2021 11:50 AM IST

New Delhi: Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier...

Novo Nordisk Education Foundation launches Chatbot, Mishti for diabetes management in India

Ruchika Sharma20 July 2021 11:15 AM IST

New Delhi: Novo Nordisk Education Foundation on Monday said it has launched Chatbot, Mishti aiming to provide access to important information to...

Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Japanese nod to Ronapreve (casirivimab and imdevimab) for treatment of mild to moderate Covid-19

Ruchika Sharma20 July 2021 10:30 AM IST

Basel: Pharma major, Roche, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve (casirivimab and...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok